Melphalan

Phase II study of oral Melphalan in two cohorts of BRCA-related or BRCA wt platinum-resistant epithelial ovarian carcinoma (EOC)

STATO: In fase di apertura
PATOLOGIA: Ovaio
CENTRO COORDINATORE MITO:
PRINCIPAL INVESTIGATOR: Ugo Federico Francesco De Giorgi
CO INVESTIGATOR: Vincenza Conteduca
STUDY COORDINATOR: Giorgia Ravaglia

DOCUMENTAZIONE

Melphalan Design Study